Diagnostic utility of C-reactive Protein combined with brain natriuretic peptide in acute pulmonary edema: A cross sectional study

Respiratory Research

Volumn 12, Issue 1, 2011, Pages

  Komiya, Kosaku ^a   Ishii, Hiroshi ^a   Teramoto, Shinji ^b   Takahashi, Osamu ^c   Eshima, Nobuoki ^a   Yamaguchi, Ou ^d   Ebi, Noriyuki ^d   Murakami, Junji ^d   Yamamoto, Hidehiko ^d   Kadota, Jun Ichi ^a  

^a OITA UNIVERSITY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Center for Clinical Epidemiology   (Japan)

^d ASO IIZUKA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; BIOLOGICAL MARKER;

ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CROSS-SECTIONAL STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EMERGENCY WARD; FEMALE; HUMAN; LUNG EDEMA; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; ACUTE DISEASE; ACUTE LUNG INJURY; BLOOD; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; CRITICAL ILLNESS; DIFFERENTIAL DIAGNOSIS; EVALUATION; IMMUNOLOGY; JAPAN; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY FAILURE; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

ACUTE DISEASE; ACUTE LUNG INJURY; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; CRITICAL ILLNESS; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; JAPAN; LOGISTIC MODELS; MALE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PULMONARY EDEMA; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 79959329488     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-83     Document Type: Article

References (41)

1. Brower RG, Ware LB, Berthiaume Y, Matthay MA: Treatment of ARDS. Chest 2001, 120:1347-1367.
2. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
3. Sloane PJ, Gee MH, Gottlieb JE, Albertine KH, Peters SP, Burns JR, Machiedo G, Fish JE: A multicenter registry of patients with acute respiratory distress syndrome. Physiology and outcome. Am Rev Respir Dis 1992, 146:419-426.
4. Monnet X, Anguel N, Osman D, Hamzaoui O, Richard C, Teboul JL: Assessing pulmonary permeability by transpulmonary thermodilution allows differentiation of hydrostatic pulmonary edema from ALI/ARDS. Intensive Care Med 2007, 33:448-453.
5. Fein A, Grossman RF, Jones JG, Overland E, Pitts L, Murray JF, Staub NC: The value of edema fluid protein measurement in patients with pulmonary edema. Am J Med 1979, 67:32-38.
6. Eisenberg PR, Jaffe AS, Schuster DP: Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients. Crit Care Med 1984, 12:549-553.
7. Mermel LA, Maki DG: Infectious complications of Swan-Ganz pulmonary artery catheters. Pathogenesis, epidemiology, prevention, and management. Am J Respir Crit Care Med 1994, 149:1020-1036.
8. Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ, Laporta DP, Viner S, Passerini L, Devitt H, Kirby A, Jacka M, Canadian Critical Care Clinical Trials Group: A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003, 348:5-14.
9. Harvey S, Harrison DA, Singer M, Ashcroft J, Jones CM, Elbourne D, Brampton W, Williams D, Young D, Rowan K, collaboration PA-Ms: Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 2005, 366:472-477.
10. Connors AF Jr, Speroff T, Dawson NV, Thomas C, Harrell FE Jr, Wagner D, Desbiens N, Goldman L, Wu AW, Califf RM, Fulkerson WJ, Vidaillet H Jr, Broste S, Bellamy P, Lynn J, Knaus WA: The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 1996, 276:889-897.
11. Montgomery AB, Stager MA, Carrico CJ, Hudson LD: Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985, 132:485-489.
12. Zimmerman GA, Morris AH, Cengiz M: Cardiovascular alterations in the adult respiratory distress syndrome. Am J Med 1982, 73:25-34.
13. Milne EN, Pistolesi M, Miniati M, Giuntini C: The radiologic distinction of cardiogenic and noncardiogenic edema. AJR Am J Roentgenol 1985, 144:879-894.
14. Aberle DR, Wiener-Kronish JP, Webb WR, Matthay MA: Hydrostatic versus increased permeability pulmonary edema: diagnosis based on radiographic criteria in critically ill patients. Radiology 1988, 168:73-79.
15. Rana R, Vlahakis NE, Daniels CE, Jaffe AS, Klee GG, Hubmayr RD, Gajic O: B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema. Crit Care Med 2006, 34:1941-1946.
16. Levitt JE, Vinayak AG, Gehlbach BK, Pohlman A, Van Cleve W, Hall JB, Kress JP: Diagnostic utility of B-type natriuretic peptide in critically ill patients with pulmonary edema: a prospective cohort study. Crit Care 2008, 12:R3.
17. Ware LB, Matthay MA: Clinical practice. Acute pulmonary edema. N Engl J Med 2005, 353:2788-2796.
18. Nagueh SF, Kopelen HA, Zoghbi WA: Feasibility and accuracy of Doppler echocardiographic estimation of pulmonary artery occlusive pressure in the intensive care unit. Am J Cardiol 1995, 75:1256-1262.
19. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP: Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004, 350:647-654.
20. Davis M, Espiner E, Richards G, Billings J, Town I, Neill A, Drennan C, Richards M, Turner J, Yandle T: Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994, 343:440-444.
21. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA: Breathing Not Properly Multinational Study, Investigators: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002, 347:161-167.
22. Karmpaliotis D, Kirtane AJ, Ruisi CP, Polonsky T, Malhotra A, Talmor D, Kosmidou I, Jarolim P, de Lemos JA, Sabatine MS, Gibson CM, Morrow D: Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest 2007, 131:964-971.
23. Januzzi JL, Morss A, Tung R, Pino R, Fifer MA, Thompson BT, Lee-Lewandrowski E: Natriuretic peptide testing for the evaluation of critically ill patients with shock in the intensive care unit: a prospective cohort study. Crit Care 2006, 10:R37.
24. Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M: Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med 2006, 34:2140-2144.
25. Tung RH, Garcia C, Morss AM, Pino RM, Fifer MA, Thompson BT, Lewandrowski K, Lee-Lewandrowski E, Januzzi JL: Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 2004, 32:1643-1647.
26. Okamura JM, Miyagi JM, Terada K, Hokama Y: Potential clinical applications of C-reactive protein. J Clin Lab Anal 1990, 4:231-235.
27. Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Melot C, Vincent JL: C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003, 123:2043-2049.
28. Smith RP, Lipworth BJ, Cree IA, Spiers EM, Winter JH: C-reactive protein. A clinical marker in community-acquired pneumonia. Chest 1995, 108:1288-1291.
29. Ware LB: Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med 2006, 27:337-349.
30. Bajwa EK, Khan UA, Januzzi JL, Gong MN, Thompson BT, Christiani DC: Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest 2009, 136:471-480.
31. Global Initiative for Asthma: Global strategy for asthma management and prevention. [ http://www.ginasthma.com ] 2008.
32. Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. [ http://www.goldcopd.com/GuidelinesResources.asp?l1=2&l2=0 ] 2010.
33. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143:29-36.
34. Grossman W: Diastolic dysfunction in congestive heart failure. N Engl J Med 1991, 325:1557-1564.
35. Gackowski A, Isnard R, Golmard JL, Pousset F, Carayon A, Montalescot G, Hulot JS, Thomas D, Piwowarska W, Komajda M: Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur Heart J 2004, 25:1788-1796.
36. Charpentier J, Luyt CE, Fulla Y, Vinsonneau C, Cariou A, Grabar S, Dhainaut JF, Mira JP, Chiche JD: Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004, 32:660-665.
37. Vieillard-Baron A, Page B, Augarde R, Prin S, Qanadli S, Beauchet A, Dubourg O, Jardin F: Acute cor pulmonale in massive pulmonary embolism: incidence, echocardiographic pattern, clinical implications and recovery rate. Intensive Care Med 2001, 27:1481-1486.
38. Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S, Kuribayashi S, Hamada S, Kakishita M, Nakanishi N, Takamiya M, Kunieda T, Matsuo H, Kangawa K: Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998, 31:202-208.
39. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT: Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003, 58:377-382.
40. Chalmers JD, Singanayagam A, Hill AT: C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008, 121:219-225.
41. Almirall J, Bolibar I, Toran P, Pera G, Boquet X, Balanzo X, Sauca G, Community-Acquired Pneumonia Maresme Study G: Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 2004, 125:1335-1342.